Product-page copy should keep literature context separate from product positioning
The clinical reference is AquaGold Fine Touch (used by licensed practitioners since 2014)
The blend combines both peptides at lower individual concentrations than you would receive from either protocol prescribed separately
Four molecule families have peer-reviewed clinical evidence supporting their use in microinfusion-style delivery: copper tripeptide GHK-Cu (collagen synthesis, gene-expression modulation), recombinant epidermal growth factor or sh-Oligopeptide-1 (keratinocyte proliferation, dermal restructuring), polydeoxyribonucleotide PDRN (adenosine A2A receptor activation, fibroblast stimulation, anti-melanogenesis), and a multi-molecular-weight hyaluronic acid system (50 kDa to 2000 kDa fractions, each with different penetration depth and biological role)
Identification of baicalein as a ferroptosis inhibitor by natural product library screening
Ipamorelin has no FDA approval